Floatz logo

Inno-206

Neoplasms, Plasma Cell

Hellenic Society of HematologyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Neoplasms, Plasma Cell cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Hellenic Society of Hematology
Phase 3BBB
Pomalidomide
Hellenic Society of Hematology
Phase 2B
Bortezomib
Hellenic Society of Hematology
Phase 2CCC
Benadryl
Hellenic Society of Hematology
Phase 2CCC
Isatuximab
Hellenic Society of Hematology
Phase 2CCC

View all 11 →

Same molecule, other indications

Inno-206 is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
77 / 100
View asset →
Recurrent Adult Acute Lymphoblastic LeukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →